CSPC

CSPC is a Chinese pharmaceutical company founded in 1997 by Sifang, generally recognized as one of the leading and most innovative integrated pharmaceutical manufacturers in China. The company specializes in researching, developing, manufacturing, and marketing various drugs in the fields of cardiovascular, cerebrovascular, antibiotic, and digestive system. CSPC has state-of-the-art production facilities and a broad portfolio of products that have been approved by the China Food and Drug Administration (CFDA) to meet the needs of different therapeutic areas.

• Cardiovascular: CSPC produces medications for hypertension, heart failure, arrhythmia, and coronary artery disease.
• Cerebrovascular: CSPC produces medications for ischemic stroke, hemorrhagic stroke, and cerebral vein thrombosis.
• Antibiotic: CSPC produces 3rd generation cephalosporins, carbapenems, and quinolones.
• Digestive system: CSPC produces medications for gastrointestinal bleeding, gastric ulcer, and reflux esophagitis.

CSPC is committed to sustainable development and has put extensive efforts into research and innovation. They have established research centers to keep up with the latest advancements in science and technology. The company has a clear focus on quality control and maintains rigorous standards throughout the manufacturing process to ensure the safety and efficacy of their products. With their dedication to innovation and quality, CSPC is poised to become a key player in the global pharmaceutical market.